chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm went numb immediately; extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger). At the time of the report, VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment information was not provided  concomitant drugs were  not reported    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: fallow up received on 27-APR-2021 patient refused for fallow up
An hour after receiving the injection in my left arm, the left side of my face and throat swelled up.; An hour after receiving the injection in my left arm, the left side of my face and throat swelled up.; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 38 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 16Apr2021 12:30 (Batch/Lot Number: EW0164) as DOSE 1, SINGLE for covid-19 immunisation  Medical history included asthma from an unknown date and unknown if ongoing , allergy to arthropod sting from an unknown date and unknown if ongoing , food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced an hour after receiving the injection in her left arm, the left side of her face and throat swelled up.on 16Apr2021 13:30 with outcome of recovering, an hour after receiving the injection in her left arm, the left side of her face and throat swelled up. causing pharyngeal swelling on 16Apr2021 13:30 with outcome of recovering. Therapeutic measures were taken as a result of this with Benadryl, ibuprofen. No follow-up attempts are possible. No further information is expected.
Severe headache, light and sound sensitivity, lethargy and fatigue.  ED visit, lumbar puncture and CT of the head completed.  Lab work sent.  Has had numerous ER visits and hospitalzations since this initial visit.
Initial report received from a healthcare professional on 07 January 2013. A 03-year-old female patient who had received first dose of FLUZONE QIV batch number U4790AA, dose, route and anatomical site of administration were not reported intramuscularly on unspecified date. Patient's medical history and illness at the time of vaccination and Concomitant medications was unknown. Patient had allergy of egg. On unspecified date, after vaccination the patient developed reaction, does not know what the reaction was. Corrective treatment and laboratory investigations was not reported. Outcome of the event was unknown. Documents held by sender: none.
I started having swelling from the shoulder down, I had site soreness nausea vomiting headache chills fever body aches general malaise  lack of appetite, worse than the flu symptoms. I still have some mile symptoms and chills on occasion. The worst of the symptoms is over. I took theraflu and hydrated I only went to the Dr for a note for work
Rash noted to left thigh 4" x 3" + redness + itching, rash occurred day of shot approximately 1-2" after, has continued to spread.
Could not hear anything 2 days post-vaccination; A spontaneous report was received from a consumer who was also a female patient, unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and could not hear anything 2 days post-vaccination.  The patient's medical history included Meniere's disease and hearing aids user. No relevant concomitant medications were reported.  On 13 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 030M20A) for prophylaxis of COVID-19 infection.  The patient received her first shot on 13 Feb 2021 and could not hear anything two days post-vaccination. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the event, could not hear anything 2 days post-vaccination, was considered resolved on 22 Feb 2020.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  The patient's medical history of Meniere's disease and use of  hearing aids is a confounder to the causality.
PATIENT ARM SWELLED FROM ELBOW TO SHOULDER. PATIENT WAS ADVISED TO ICE ARM AND TAKE BENADRYL IF IT GOT WORSE THEN PATIENT WAS INSTRUCTED TO GO TO EMERGENCY OR CALL 911.
Fever for 3 days and I am filling this report on day 3 and no signs of fever stopping. Fever of 102.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2014, the patient was inoculated with ZOSTAVAX by a healthcare provider to obtain permanent prevention and protection against shingles and zoster-related injuries (dose, route, and lot # not provided). On an unknown date, the patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of patient's injuries. The patient was treated by a healthcare provider for shingles in 2015. The lawyer reported that as a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death- aggravation of preexisting conditions and activation- of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
pt recvd vax 2NOV93; sore arm & cold sx devel-pt hospitalized on 5NOV by MD for pneumonia;
first Shingrix dose 6/17/2020 /  received his second dose 6/11/2121; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix on 17th June 2020).   On 10th June 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 10th June 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: This case was reported by patient himself. The patient received 2nd dose of Shingrix, more than recommended interval, which led to lengthening of vaccination schedule. At that time of 1st dose the pharmacist told him it would be a year before he needed his 2nd dose. The reporter also mentioned that, he should had gotten it within 2 to 6 months after the 1st dose and would like to know if he was ok, or should restart the series. The reporter consented to follow up.
Patient reported pain and redness at injection site as well as increased blood pressure. Patient notes he felt really sick afterwards and proceeded to the ER where he was diagnosed with Community acquired pneumonia.
pt recv vax 6MAY98 & on 7MAY area size of twenty five cent red & swollen;1MAY pt c/o rt arm hurting-area hard, swollen & hot 2 1/2 x 3cm yesterday;red, hot to touch, swollen & tender today;pyogenic abscess vs local rxn;
This spontaneous report as received from registered nurse refers to an unspecified number of patients (age and gender were not reported) who received GARDASIL lot # H017698 exp. date 02-JUL-2015 (dose and route not reported) on an unknown administration dates that was exposed to less than 31f for 8 days. The GARDASIL in question was found to be unsupported by in-house stability data. No adverse symptoms reported. the patient's outcomes were not reported. Additional information has been requested.
He has been quarantined since his wife tested positive.; This case is considered as invalid as there is no indication that the patient experienced an event under BNT162b2.  This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 02Aug2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller stated that he and his wife both got their first Pfizer Covid 19 vaccine on 02Aug2021. The caller confirms the information provided. He was calling because it's time for him to receive his second Covid 19 vaccine tomorrow, 24Aug2021. He states he had the Covid 19 vaccine and did fine. He wants to know how long, if any time, does he have to wait to receive his second Covid 19 vaccine. He is scheduled to receive his second dose tomorrow, 24Aug2021 and he had a home Covid 19 virus test, and it was negative, and he hasn't had any other issues or symptoms in the last 12 days. He wants to get the second dose, but the pharmacist said he had to have a negative Covid 19 virus test before getting the second Covid 19 vaccine and someone else told him he had to wait until after his quarantine time and he should be ok to get the second dose. The patient underwent lab tests and procedures which included sars-cov-2 test negative on an unspecified date. The outcome of the event was unknown.  Information about lot/batch number has been requested. This follow up is being submitted to amend previously reported information, Case reassessed as invalid. This case is being deleted from the database for the following reason Existence of an adverse event not confirmed at follow-up.
Moderna vaccines given on 1/5/21 and 2/1/21 at long term care facility.  Patient tested positive for COVID on 8/22/2021.  Patient died on 9/6/21 with cause of death documented as sudden respiratory arrest and COVID 19.
patient felt hot at end of 30 min observation with a BP of 143/84. 15 min later BP was 131/84 still felt hot, another 15 min BP was 127/69 and feeling of hot passed.
About 3 days (72 hours) after getting my 2nd Covid vaccine dose, I developed mild congestion that worsened over the next 24 hours into runny nose and cough by the end of day 4.  I called the pharmacist to see if this may be a reaction to the shot and they said no, likely a cold.  Sinuses and cough cleared up after 3 days, which put us at day 6 after the shot.  (Shot received Tuesday, 10/12/21, congestion starts 10/15/21, clears up by end of 10/18/21).  On 10/19/21, I woke up after a good night's sleep, no stuffiness, but could not smell anything.  Loss of sense of smell is a Covid sign.  I never had a fever, but timing is suspicious between the shot and onset of symptoms.  Loss of sense of smell is the only remaining symptom.
Wed: 12 hrs after shot - arm sore. Thurs: 24 hrs after, upper arm was red, swollen, warm about size of baseball. Later that afternoon my entire upper arm (all the way to bend in arm plus 2 1/2" past crazy bone on back side) was very sore, red, swollen, warm and I was running a low grade fever and had chills. Some improvement by Fri. afternoon. Mostly gone by Sat. except my upper arm was yellowish like a fading bruise. Both shots were given in same arm and same area.
Between 36 and 40 hours after shot (early Saturday AM), my RIGHT arm began to itch in the unhairy area to a degree that disturbed my sleep.  I applied cortisone cream.   About two hours later, BOTH arms were itching in the hairy areas.  I applied cortisone cream to affected areas.  A seeping sore eventually developed on each arm, and I started applying Clobestasol Propionate (leftover from prior eczema treatment) to those spots twice daily in addition to cortisone on other arm areas.  After contacting my doctor's office via email, I was advised to continue with my self-administered treatments (but not use Clobestasol for more than two weeks and schedule doctor visit if rash/sores do not subside), and suggested I take antihistamine such as Zyrtec shortly after second vaccine shot to possibly prevent recurrence of reaction.  Not yet recovered from rashes/sores, but treatments greatly alleviate symptoms.
One week after injection, COVID19 injection site on left arm became a tiny red bump and scar from vaccine (below COVID19 injection site) became a red bump too. Next day, big rash/hive patch appeared on the middle of the upper left arm.
In the week following the vaccine I began to experience numbness in arm, confusion, slurred speach, numbness and drooling in left side of face, balance issues and extreme fatigue and memory loss. On July 26, 2021 I went to ER and CT scan and MRI showed strokes in right side of brain that recently occurred in the week(s) prior.
Received flu shot yesterday 24 hr later - "bump" where shot given & itchy. 2 plus cm raised sl red lesion (L)  deltoid area. Denies any problems breathing. Diphenhydramine 25 mg 1 tab QID #4 (pm) and hydrocortisone cream aid pain given RTC 1 week.
The individual complained of severe stomach pain - called 9-1-1 was unable to be revived.
About 5 minutes after the vaccination, the patient became diaphoretic and pale.  Patient stated she felt "fuzzy."  Patient's mom noticed some swelling around patient's nose and mouth.  Patient was give 25mg of diphenhydramine and water to drink.  Patient also complained of nausea.  After about 30 minutes, patient was feeling better and went home.  Patient was able to walk unassisted to her vehicle.
Patient received a dose of vaccine that may have been stored outside of refrigerated temperature for more than 12 hours.
twitch / Lip twitch; Bain zap; This case was reported by a consumer via call center representative and described the occurrence of twitching facial in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included anti-depressant medication (patient claims that she has had a history of brain zaps from stopping anti-depressant medications in the past).   On 2nd August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 2nd August 2019, less than a day after receiving Shingrix, the patient experienced twitching facial. In August 2019, the patient experienced brain disorder nos. On an unknown date, the outcome of the twitching facial was recovering/resolving and the outcome of the brain disorder nos was recovered/resolved.   It was unknown if the reporter considered the twitching facial and brain disorder nos to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm The patient reported that after receiving the Shingrix vaccine, she experienced a lip twitch on her lower lip on the left side that started the night of vaccination and was still unresolved.  Less than a week after vaccination the patient also reported brain zaps.  The patient claimed that she had a history of brain zaps from stopping anti-depressant medications in the past so she was familiar with the feeling.  The patient claimed that the brain zaps remained for a couple of nights and then subsided.  The patient did not provide any specific names of her previous anti-depressant medications. The reporter gave permission to follow up.
Tingling to the arm of the site injected, more pronounced on the fingertips.; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE PARAESTHESIA (Tingling to the arm of the site injected, more pronounced on the fingertips.) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D214) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Dextromethorphan).    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced INJECTION SITE PARAESTHESIA (Tingling to the arm of the site injected, more pronounced on the fingertips.). At the time of the report, INJECTION SITE PARAESTHESIA (Tingling to the arm of the site injected, more pronounced on the fingertips.) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product information was provided.  Treatment information was not provided.   Reporter did not allow further contact
This spontaneous report as received from a physician refers to a patient of unknown age. On 21-OCT-2013 the patient was inadvertently administered with VARIVAX (lot number, indication and injection site were not reported) (0.5 ml, subcutaneous) and PROQUAD (Merck) (lot number indication and injection site were not reported) (0.5 ml, subcutaneous) on the same day. No adverse effects reported. The outcome and action taken were not provided. It was unspecified if the patient sought any medical attention. Additional information has been requested.
Started with deep hollow cough from the lungs, not bad at first, has gotten worse since, now I have a fever and weakness, I think the vaccine gave me the illness.
pain during injection; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In 2019, the patient received the 1st dose of Shingrix. In 2019, immediately after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional information was received as follows: The patient received the first dose of the Shingrix vaccine around Spring 2019 and second dose July 2019 (for tolerance of seocnd dose refer linked case : US2020AMR167324) both in her right arm. The reporter reported that while getting the first dose, the pharmacist jabbed the patient's arm while administering the vaccine, and she had pain during injection. The patient continued to have pain around the injection site in her right arm. The pain was not on the injection site. The pain was off and on and pain was mostly when she would wake up from her sleep. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR167324:2nd dose
HEADACHE; INJECTION SITE PAIN; FATIGUE; SUBCONJUNCTIVAL HEMORRHAGE; This spontaneous report received from a consumer concerned a 56 year old male.  The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029 expiry: UNKNOWN) dose was not reported, 1 total, administered on 21-MAR-2021  at right arm for prophylactic vaccination. No concomitant medications were reported.  On 21-MAR-2021, the patient had red left eye as per reporter who was HCP the patient experienced subconjunctival hemorrhage. The patient also experienced headache, injection site pain, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the subconjunctival hemorrhage, headache, injection site pain and fatigue was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: 20210424915 -COVID-19 VACCINE AD26.COV2.S- subconjunctival hemorrhage. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
This is a 19-year-old male, who recently recovered from a flu like illness with fever and myalgias a week ago. He then received an immunization against meningitis on 12/26/2017. He subsequently developed fever which has persisted and now presents for further care. He has had myalgias and arthralgias. He has had no cough. He denies having any chest pain. He has had some slight congestion. He denies having abdominal pain or urinary symptoms. He has had no rash. No sinus pain or ear pain. No neck stiffness. No other associated symptoms or complaints.
Took the injection in left shoulder.  Shoulder and arm red and itching immediately spreading to right arm,  back,  chest, and lower torso feels like sandpaper under my skin.  It may have set off a recurrence of vertigo except that the vomiting was replaced by explosive bowel movements.  This is two weeks later.  I still experience weakness in both arms  and aching pain in my hands and knees.
pain/swelling/heat at site; low-grade temp (99.3), chills, joint and muscle aches, fatigue, headache.  Treatment:  slept entire day after the vaccine.  Much improved by that night and symptoms gone the next morning (except for mild pain at vaccination site).
This spontaneous report was received from a healthcare worker referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On 12-FEB-2016, the patient was vaccinated with a dose of VAQTA (lot # L002717 and expiration date June 2017, unknown route), which was exposed to temperature outside of the recommended range. There were no concomitant medications provided. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
hot induration entire upper lateral arm w/in 2 days of receiving vax-another pt got one rxn from same vial;